Parents' Perspectives on the Utility of Genomic Sequencing in the Neonatal Intensive Care Unit
BACKGROUND: It is critical to understand the wide-ranging clinical and non-clinical effects of genome sequencing (GS) for parents in the NICU context. We assessed parents' experiences with GS as a first-line diagnostic tool for infants with suspected genetic conditions in the NICU.
METHODS: Parents of newborns (N = 62) suspected of having a genetic condition were recruited across five hospitals in the southeast United States as part of the SouthSeq study. Semi-structured interviews (N = 78) were conducted after parents received their child's sequencing result (positive, negative, or variants of unknown significance). Thematic analysis was performed on all interviews.
RESULTS: Key themes included that (1) GS in infancy is important for reproductive decision making, preparing for the child's future care, ending the diagnostic odyssey, and sharing results with care providers; (2) the timing of disclosure was acceptable for most parents, although many reported the NICU environment was overwhelming; and (3) parents deny that receiving GS results during infancy exacerbated parent-infant bonding, and reported variable impact on their feelings of guilt.
CONCLUSION: Parents reported that GS during the neonatal period was useful because it provided a "backbone" for their child's care. Parents did not consistently endorse negative impacts like interference with parent-infant bonding.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Journal of personalized medicine - 13(2023), 7 vom: 21. Juni |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
Genome sequencing |
---|
Anmerkungen: |
Date Revised 01.08.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jpm13071026 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360115098 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360115098 | ||
003 | DE-627 | ||
005 | 20231226082325.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jpm13071026 |2 doi | |
028 | 5 | 2 | |a pubmed24n1200.xml |
035 | |a (DE-627)NLM360115098 | ||
035 | |a (NLM)37511639 | ||
035 | |a (PII)1026 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lemke, Amy A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Parents' Perspectives on the Utility of Genomic Sequencing in the Neonatal Intensive Care Unit |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.08.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a BACKGROUND: It is critical to understand the wide-ranging clinical and non-clinical effects of genome sequencing (GS) for parents in the NICU context. We assessed parents' experiences with GS as a first-line diagnostic tool for infants with suspected genetic conditions in the NICU | ||
520 | |a METHODS: Parents of newborns (N = 62) suspected of having a genetic condition were recruited across five hospitals in the southeast United States as part of the SouthSeq study. Semi-structured interviews (N = 78) were conducted after parents received their child's sequencing result (positive, negative, or variants of unknown significance). Thematic analysis was performed on all interviews | ||
520 | |a RESULTS: Key themes included that (1) GS in infancy is important for reproductive decision making, preparing for the child's future care, ending the diagnostic odyssey, and sharing results with care providers; (2) the timing of disclosure was acceptable for most parents, although many reported the NICU environment was overwhelming; and (3) parents deny that receiving GS results during infancy exacerbated parent-infant bonding, and reported variable impact on their feelings of guilt | ||
520 | |a CONCLUSION: Parents reported that GS during the neonatal period was useful because it provided a "backbone" for their child's care. Parents did not consistently endorse negative impacts like interference with parent-infant bonding | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a genome sequencing | |
650 | 4 | |a parental guilt | |
650 | 4 | |a parent–infant bonding | |
650 | 4 | |a timing of disclosure of results | |
650 | 4 | |a utility | |
700 | 1 | |a Thompson, Michelle L |e verfasserin |4 aut | |
700 | 1 | |a Gimpel, Emily C |e verfasserin |4 aut | |
700 | 1 | |a McNamara, Katelyn C |e verfasserin |4 aut | |
700 | 1 | |a Rich, Carla A |e verfasserin |4 aut | |
700 | 1 | |a Finnila, Candice R |e verfasserin |4 aut | |
700 | 1 | |a Cochran, Meagan E |e verfasserin |4 aut | |
700 | 1 | |a Lawlor, James M J |e verfasserin |4 aut | |
700 | 1 | |a East, Kelly M |e verfasserin |4 aut | |
700 | 1 | |a Bowling, Kevin M |e verfasserin |4 aut | |
700 | 1 | |a Latner, Donald R |e verfasserin |4 aut | |
700 | 1 | |a Hiatt, Susan M |e verfasserin |4 aut | |
700 | 1 | |a Amaral, Michelle D |e verfasserin |4 aut | |
700 | 1 | |a Kelley, Whitley V |e verfasserin |4 aut | |
700 | 1 | |a Greve, Veronica |e verfasserin |4 aut | |
700 | 1 | |a Gray, David E |e verfasserin |4 aut | |
700 | 1 | |a Felker, Stephanie A |e verfasserin |4 aut | |
700 | 1 | |a Meddaugh, Hannah |e verfasserin |4 aut | |
700 | 1 | |a Cannon, Ashley |e verfasserin |4 aut | |
700 | 1 | |a Luedecke, Amanda |e verfasserin |4 aut | |
700 | 1 | |a Jackson, Kelly E |e verfasserin |4 aut | |
700 | 1 | |a Hendon, Laura G |e verfasserin |4 aut | |
700 | 1 | |a Janani, Hillary M |e verfasserin |4 aut | |
700 | 1 | |a Johnston, Marla |e verfasserin |4 aut | |
700 | 1 | |a Merin, Lee Ann |e verfasserin |4 aut | |
700 | 1 | |a Deans, Sarah L |e verfasserin |4 aut | |
700 | 1 | |a Tuura, Carly |e verfasserin |4 aut | |
700 | 1 | |a Hughes, Trent |e verfasserin |4 aut | |
700 | 1 | |a Williams, Heather |e verfasserin |4 aut | |
700 | 1 | |a Laborde, Kelly |e verfasserin |4 aut | |
700 | 1 | |a Neu, Matthew B |e verfasserin |4 aut | |
700 | 1 | |a Patrick-Esteve, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Hurst, Anna C E |e verfasserin |4 aut | |
700 | 1 | |a Kirmse, Brian M |e verfasserin |4 aut | |
700 | 1 | |a Savich, Renate |e verfasserin |4 aut | |
700 | 1 | |a Spedale, Steven B |e verfasserin |4 aut | |
700 | 1 | |a Knight, Sara J |e verfasserin |4 aut | |
700 | 1 | |a Barsh, Gregory S |e verfasserin |4 aut | |
700 | 1 | |a Korf, Bruce R |e verfasserin |4 aut | |
700 | 1 | |a Cooper, Gregory M |e verfasserin |4 aut | |
700 | 1 | |a Brothers, Kyle B |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of personalized medicine |d 2011 |g 13(2023), 7 vom: 21. Juni |w (DE-627)NLM228113881 |x 2075-4426 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:7 |g day:21 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jpm13071026 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 7 |b 21 |c 06 |